Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients

doi:10.3748/wjg.v24.i11.1206

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7700)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

601

WORD

223

HTML

4606

Figures (1-6)

282

Tables (1-4)

251

Sum=5963

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

874

Download

863

Sum=1737

Mar 21, 2018 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Mar 21, 2018; 24(11): 1206-1215
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1206

Full Size Figure Download Figure

Figure 1 The volcano plot of the differentially expressed miRNAs. A total of 110 DEMs were identified between 20 pairs of GC patients and adjacent normal tissues (cut-off criteria are P < 0.05 and fold change > 2.0). The green and red spots represent downregulated and upregulated miRNAs, respectively. DEMs: Differentially expressed miRNAs; GC: Gastric cancer.

Citation: Zhang C, Zhang CD, Ma MH, Dai DQ. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. World J Gastroenterol 2018; 24(11): 1206-1215
URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1206.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i11.1206